These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 23996011

  • 21. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization.
    Yu CM, Wang L, Chau E, Chan RH, Kong SL, Tang MO, Christensen J, Stadler RW, Lau CP.
    Circulation; 2005 Aug 09; 112(6):841-8. PubMed ID: 16061743
    [Abstract] [Full Text] [Related]

  • 22. Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.
    Alam MB, Munir MB, Rattan R, Flanigan S, Adelstein E, Jain S, Saba S.
    Europace; 2014 Feb 09; 16(2):246-51. PubMed ID: 24099864
    [Abstract] [Full Text] [Related]

  • 23. Intrathoracic impedance monitoring to detect chronic heart failure deterioration: relationship to changes in NT-proBNP.
    Lüthje L, Vollmann D, Drescher T, Schott P, Zenker D, Hasenfuss G, Unterberg C.
    Eur J Heart Fail; 2007 Feb 09; 9(6-7):716-22. PubMed ID: 17462948
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of thoracic impedance trends for implant-based remote monitoring in heart failure patients - Results from the (J-)HomeCARE-II Study.
    Maier SKG, Paule S, Jung W, Koller M, Ventura R, Quesada A, Bordachar P, García-Fernández FJ, Schumacher B, Lobitz N, Takizawa K, Ando K, Adachi K, Shoda M.
    J Electrocardiol; 2019 Feb 09; 53():100-108. PubMed ID: 30739055
    [Abstract] [Full Text] [Related]

  • 25. Prediction of All-Cause Mortality Based on the Direct Measurement of Intrathoracic Impedance.
    Zile MR, Sharma V, Johnson JW, Warman EN, Baicu CF, Bennett TD.
    Circ Heart Fail; 2016 Jan 09; 9(1):e002543. PubMed ID: 26699393
    [Abstract] [Full Text] [Related]

  • 26. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
    Lenarczyk R, Kowalski O, Sredniawa B, Pruszkowska-Skrzep P, Mazurek M, Jędrzejczyk-Patej E, Woźniak A, Pluta S, Głowacki J, Kalarus Z.
    J Cardiovasc Electrophysiol; 2012 Nov 09; 23(11):1228-36. PubMed ID: 22651239
    [Abstract] [Full Text] [Related]

  • 27. Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure.
    Catanzariti D, Lunati M, Landolina M, Zanotto G, Lonardi G, Iacopino S, Oliva F, Perego GB, Varbaro A, Denaro A, Valsecchi S, Vergara G, Italian Clinical Service Optivol-CRT Group.
    Pacing Clin Electrophysiol; 2009 Mar 09; 32(3):363-70. PubMed ID: 19272067
    [Abstract] [Full Text] [Related]

  • 28. Temporal associations between thoracic volume overload and malignant ventricular arrhythmias: a study of intrathoracic impedance.
    Ip JE, Cheung JW, Park D, Hellawell JL, Stein KM, Iwai S, Liu CF, Lerman BB, Markowitz SM.
    J Cardiovasc Electrophysiol; 2011 Mar 09; 22(3):293-9. PubMed ID: 20946226
    [Abstract] [Full Text] [Related]

  • 29. Integrating device-based monitoring into clinical practice: insights from a large heart failure clinic.
    Small RS.
    Am J Cardiol; 2007 May 21; 99(10A):17G-22G. PubMed ID: 17512418
    [Abstract] [Full Text] [Related]

  • 30. Change in intrathoracic impedance measures during acute decompensated heart failure admission: results from the Diagnostic Data for Discharge in Heart Failure Patients (3D-HF) Pilot Study.
    Whellan DJ, Droogan CJ, Fitzpatrick J, Adams S, McCarey MM, Andrel J, Mather P, Rubin S, Bonita R, Keith S.
    J Card Fail; 2012 Feb 21; 18(2):107-12. PubMed ID: 22300777
    [Abstract] [Full Text] [Related]

  • 31. Monitoring of Daily Body Weight and Intrathoracic Impedance in Heart Failure Patients With a High Risk of Volume Overload Decompensation.
    Gudmundsson K, Lyngå P, Rosenqvist M, Braunschweig F.
    Clin Cardiol; 2016 Aug 21; 39(8):446-52. PubMed ID: 27175605
    [Abstract] [Full Text] [Related]

  • 32. Long-term effectiveness of the combined minute ventilation and patient activity sensors as predictor of heart failure events in patients treated with cardiac resynchronization therapy: Results of the Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT device Trial (CLEPSYDRA) study.
    Auricchio A, Gold MR, Brugada J, Nölker G, Arunasalam S, Leclercq C, Defaye P, Calò L, Baumann O, Leyva F.
    Eur J Heart Fail; 2014 Jun 21; 16(6):663-70. PubMed ID: 24639140
    [Abstract] [Full Text] [Related]

  • 33. Review of advanced heart failure device diagnostics examined in clinical trials and the potential benefit from monitoring capabilities.
    Whellan DJ, Adams S, Bowerman L.
    Prog Cardiovasc Dis; 2011 Jun 21; 54(2):107-14. PubMed ID: 21875510
    [Abstract] [Full Text] [Related]

  • 34. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST).
    Abraham WT, Compton S, Haas G, Foreman B, Canby RC, Fishel R, McRae S, Toledo GB, Sarkar S, Hettrick DA, FAST Study Investigators.
    Congest Heart Fail; 2011 Jun 21; 17(2):51-5. PubMed ID: 21449992
    [Abstract] [Full Text] [Related]

  • 35. Intrathoracic impedance and ultrasound lung comets in heart failure deterioration monitoring.
    Maines M, Catanzariti D, Angheben C, Valsecchi S, Comisso J, Vergara G.
    Pacing Clin Electrophysiol; 2011 Aug 21; 34(8):968-74. PubMed ID: 21477028
    [Abstract] [Full Text] [Related]

  • 36. OptiVol fluid status monitoring with an implantable cardiac device: a heart failure management system.
    Yamokoski LM, Haas GJ, Gans B, Abraham WT.
    Expert Rev Med Devices; 2007 Nov 21; 4(6):775-80. PubMed ID: 18035943
    [Abstract] [Full Text] [Related]

  • 37. OptiVol fluid index: does an association with ventricular arrhythmias hold water?
    Sullivan RM, Olshansky B.
    J Cardiovasc Electrophysiol; 2011 Mar 21; 22(3):300-1. PubMed ID: 21091968
    [No Abstract] [Full Text] [Related]

  • 38. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).
    Braunschweig F, Ford I, Conraads V, Cowie MR, Jondeau G, Kautzner J, Lunati M, Munoz Aguilera R, Man Yu C, Marijianowski M, Borggrefe M, van Veldhuisen DJ, DOT-HF steering committee and investigators.
    Eur J Heart Fail; 2008 Sep 21; 10(9):907-16. PubMed ID: 18715826
    [Abstract] [Full Text] [Related]

  • 39. Relationship of paroxysmal atrial tachyarrhythmias to volume overload: assessment by implanted transpulmonary impedance monitoring.
    Jhanjee R, Templeton GA, Sattiraju S, Nguyen J, Sakaguchi S, Lu F, Ermis C, Milstein S, Van Heel L, Lurie KG, Benditt DG.
    Circ Arrhythm Electrophysiol; 2009 Oct 21; 2(5):488-94. PubMed ID: 19843916
    [Abstract] [Full Text] [Related]

  • 40. Feasibility of using multivector impedance to monitor pulmonary congestion in heart failure patients.
    Binkley PF, Porterfield JG, Porterfield LM, Beau SL, Corbisiero R, Greer GS, Love CJ, Turkel M, Bjorling A, Qu F, Farazi TG.
    J Interv Card Electrophysiol; 2012 Nov 21; 35(2):197-206. PubMed ID: 22688951
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.